[1] van Lieshout JH, Dibue-Adjei M, Cornelius JF, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage [J]. Neurosurg Rev, 2018, 41(4):917-930.
[2] Serrone JC, Maekawa H, Tjahjadi M, et al. Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions[J]. Expert Rev Neurother, 2015,15(4):367-380.
[3] Edjlali M, Rodriguez-Regent C, Hodel J, et al. Subarachnoid hemorrhage in ten questions[J]. Diagn Interv Imaging, 2015,96(78):657-666.
[4] Penn DL, Witte SR, Komotar RJ, et al. Pathological mechanisms underlying aneurysmal subarachnoid haemorrhage and vasospasm[J]. J Clin Neurosci, 2015,22(1):1-5.
[5] Lawton MT, Vates GE. Subarachnoid Hemorrhage [J]. N Engl J Med, 2017,377(3):257-266.
[6] Macdonald RL, Diringer MN, Citerio G. Understanding the disease: aneurysmal subarachnoid hemorrhage[J]. Intensive Care Med, 2014,40(12):1940-1943.
[7] Suzuki H. What is early brain injury [J]? Transl Stroke Res, 2015, 6(1):1-3.
[8] Fontana J, Moratin J, Ehrlich G, et al. Dynamic autoregulatory response after aneurysmal subarachnoid hemorrhage and its relation to angiographic vasospasm and clinical outcome[J]. Neurocrit Care, 2015, 23(3):355-363.
[9] Balbi M, Koide M, Schwarzmaier SM, et al. Acute changes in neurovascular reactivity after subarachnoid hemorrhage in vivo[J]. J Cereb Blood Flow Metab, 2017, 37(1):178-187.
[10] Scholler K, Trinkl A, Klopotowski M, et al. Characterization of microvascular basal lamina damage and bloodbrain barrier dysfunction following subarachnoid hemorrhage in rats [J]. Brain Res, 2007, 1142:237-246.
[11] Chen S, Luo J, Reis C, et al. Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment[J]. Biomed Res Int, 2017, 2017:8584753.
[12] Li Z, Liang G, Ma T, et al. Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage[J]. Metab Brain Dis, 2015,30(2):597-603.
[13] Hayman EG, Wessell A, Gerzanich V, et al. Mechanisms of global cerebral edema formation in aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2017, 26(2):301-310.
[14] Yuksel S, Tosun YB, Cahill J, et al. Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis [J]. Turk Neurosurg, 2012, 22(5):529-533.
[15] Li H, Yu JS, Zhang HS, et al. Increased expression of Caspase-12 after experimental subarachnoid hemorrhage [J]. Neurohem Res, 2016, 41(12):3407-3416.
[16] Miller BA, Turan N, Chau M, et al. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage[J]. Biomed Res Int, 2014, 2014:384342.
[17] Lucke-Wold BP, Logsdon AF, Manoranjan B, et al. Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review[J]. Int J Mol Sci, 2016, 17(4):497.
[18] Nogueira AB, Nogueira AB, Esteves Veiga JC, et al. Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage[J]. Neurosurgery, 2014, 75(6):678-689.
[19] Farooqui AA. n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation [J]. Curr Med Chem, 2012, 19(4):532-543.
[20] Garcia JM, Stillings SA, Leclerc JL, et al. Role of interleukin-10 in acute brain injuries[J]. Front Neurol, 2017, 8:244.
[21] Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology[J]. Curr Atheroscler Rep, 2017, 19(12):50.
[22] Drazin D, Fennell VS, Gifford E, et al. Safety and outcomes of simultaneous vasospasm and endovascular aneurysm treatment (SVAT) in subarachnoid hemorrhage[J]. J Neurointerv Surg, 2017, 9(5):482-485.
[23] Yousef KM, Balzer JR, Bender CM, et al. Cerebral perfusion pressure and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J]. Am J Crit Care, 2015,24(4):e65-e71.
[24] Ciurea AV, Palade C, Voinescu D, et al. Subarachnoid hemorrhage and cerebral vasospasm-literature review[J]. J Med Life, 2013,6(2):120-125.
[25] Huang Q, Wang G, Hu YL, et al. Study on the expression and mechanism of inflammatory factors in the brain of rats with cerebral vasospasm[J]. Eur Rev Med Pharmacol Sci, 2017,21(12):2887-2894.
[26] Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association[J]. Stroke, 2012,43(6):1711-1737.
[27] Santos-Teles AG, Passos RH, Panerai RB, et al. Intravenous administration of milrinone, as an alternative approach to treat vasospasm in subarachnoid hemorrhage: a case report of transcranial doppler monitoring[J]. Clin Case Rep, 2019,7(4):648-652.
[28] Frontera JA, Provencio JJ, Sehba FA, et al. The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage[J]. Neurocrit Care, 2017,26(1):48-57.
[29] Lin CL, Dumont AS, Zhang JH, et al. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies[J]. Biomed Res Int, 2014,2014:679014.
[30] Guvenc Tuna B, Lachkar N, de Vos J, et al. Cerebral artery remodeling in rodent models of subarachnoid hemorrhage[J]. J Vasc Res, 2015,52(2):103-115.
[31] McConnell ED, Wei HS, Reitz KM, et al. Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase[J]. J Cereb Blood Flow Metab, 2016,36(9):1537-1552.
[32] Sangeetha RP, Ramesh VJ, Kamath S, et al. Effect of remote ischemic preconditioning on cerebral vasospasm and biomarkers of cerebral ischemia in aneurysmal subarachnoid hemorrhage (ERVAS): a protocol for a randomized, controlled pilot trial[J]. Brain Circ, 2019,5(1):12-18.
[33] D’Souza S. Aneurysmal subarachnoid hemorrhage[J]. J Neurosurg Anesthesiol, 2015, 27 (3): 222-240.
[34] Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature [J]. Physiol Rev, 2015,95(3):953-993.
[35] Hartings JA, Shuttleworth CW, Kirov SA, et al. The continuum of spreading depolarizations in acute cortical lesion development: examining leao’s legacy[J]. J Cereb Blood Flow Metab, 2017, 37(5):1571-1594.
[36] Foreman B. The pathophysiology of delayed cerebral ischemia[J]. J Clin Neurophysiol, 2016,33(3):174-182.
[37] Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease[J]. Nat Med, 2011,17(4):439-447.
[38] Oka F, Hoffmann U, Lee JH, et al. Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents[J]. J Cereb Blood Flow Metab, 2017,37(5):1829-1840.
[39] Wainsztein N, Rodriguez Lucci F. Cortical Spreading depression and ischemia in neurocritical patients[J]. Neurol Clin, 2017,35(4):655-664.
[40] Chung DY, Oka F, Ayata C. Spreading depolarizations: a therapeutic target against delayed cerebral ischemia after subarachnoid hemorrhage[J]. J Clin Neurophysiol, 2016, 33(3): 196-202.
|